weke delen van het gelaat benign pituitary tumor that produces growth-hormone growth-hormone producing pituitary adenoma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The subjects are adult patients with acromegaly, who are in remission with only transsphenoidale pituitary surgery treatment, and still visit the outpatient clinic of the department of Endocrinology. Remission is defined as disappearance of clinical symptoms of active GH hypersecretion with in addition normal IGF-1 levels (
Exclusion criteria
Exclusion criteria: Patients may not participate in the study if they are pregnant or received oral/maxillofacial surgical treatment in the past.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The comparison of cephalometricand facial analyses of both 3D stereophotography and 3D cone beam CT data in patients with acromegaly and healthy subjects.Furthermore, the average face scan be computed based on the 3D photographs acquired in this study. An average face will be computed for acromegalic patients and healthy subjects. After computation, the average faces can be compared to analyze the overall differences in facial differences between both groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| The following parameters will also be collected: sex, date of birth, length, weight, oral/maxillofacial surgical treatment in the past, pre-operative IGF-1, GH and oral glucose tolerance test, pituitary MRI results (micro/macro adenoma), date of diagnosis, date of operation, post-operative IGF-1, GH and oral glucose tolerance test, duration of follow-up, last IGF-1 result and presence of hypopituitarism. | — |
Countries
Netherlands